Cell Therapy ASH 2024 Post Conference Report
There were 198 cell therapy related abstracts identified at ASH 2024.
Our cell therapy ASH 2024 report, provides key cell therapy abstract highlights and analysis, enabling you to stay ahead of the curve with cell therapy innovation in the hematology disease indication space.
The Cell Therapy ASH 2024 Report Includes:
- An abstract analysis and breakdown of Clinical Trial Phase and Therapeutic Class
- The identification of the most popular Targets studied across all cell therapy relevant abstracts
- Clinical & Pre-Clinical Abstract Summaries
Find out more
Beacon is the essential decision-support tool for developers of complex therapeutics. Our market-defining, proprietary ontologies, combined with the most accurate and comprehensive life sciences data, provide our customers with unparalleled visibility of the drug and trial landscape.
With Beacon, you can make drug development decisions with confidence. This is why 23 of the world’s top 25 drug developers trust us.
